Omeros (OMER) Cash from Operations Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.46% |
| Dec 31, 2025 | -16.70% |
| Sep 30, 2025 | 11.99% |
| Jun 30, 2025 | 10.20% |
| Mar 31, 2025 | -31.42% |
| Dec 31, 2024 | -4.72% |
| Sep 30, 2024 | -33.64% |
| Jun 30, 2024 | -22.62% |
| Mar 31, 2024 | -26.40% |
| Dec 31, 2023 | -7.15% |
| Sep 30, 2023 | 2.41% |
| Jun 30, 2023 | -0.91% |
| Mar 31, 2023 | 77.16% |
| Dec 31, 2022 | -43.49% |
| Sep 30, 2022 | -18.76% |
| Jun 30, 2022 | -19.00% |
| Mar 31, 2022 | -3.65% |
| Dec 31, 2021 | -10.89% |
| Sep 30, 2021 | -16.10% |
| Jun 30, 2021 | -16.61% |
| Mar 31, 2021 | -19.34% |
| Dec 31, 2020 | -2.09% |
| Sep 30, 2020 | -19.09% |
| Jun 30, 2020 | -17.84% |
| Mar 31, 2020 | 12.16% |
| Dec 31, 2019 | -7.96% |
| Sep 30, 2019 | 13.95% |
| Jun 30, 2019 | -1.67% |
| Mar 31, 2019 | -3.06% |
| Dec 31, 2018 | -142.18% |
| Sep 30, 2018 | -27.28% |
| Jun 30, 2018 | -26.90% |
| Mar 31, 2018 | -4.72% |
| Dec 31, 2017 | 20.07% |
| Sep 30, 2017 | -8.63% |
| Jun 30, 2017 | 1.64% |
| Mar 31, 2017 | -18.20% |
| Dec 31, 2016 | -8.09% |
| Sep 30, 2016 | -22.26% |
| Jun 30, 2016 | -15.13% |
| Mar 31, 2016 | -16.12% |
| Dec 31, 2015 | -35.14% |
| Sep 30, 2015 | -19.86% |